Download PDF

1. Company Snapshot

1.a. Company Description

Philip Morris International Inc.operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector.The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States.


The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix.It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands.In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines.


The company sells its smoke-free products in 71 markets.Philip Morris International Inc.was incorporated in 1987 and is headquartered in New York, New York.

Show Full description

1.b. Last Insights on PM

Philip Morris International's recent performance was negatively impacted by a revenue miss in the second quarter, driven by a decline in cigarette sales and lower-than-expected shipments of its ZYN nicotine pouches. The company's premium valuation and cigarette declines also urge cautious investment moves. Additionally, Philip Morris' smoke-free growth, while strong, is not enough to offset the decline in traditional cigarette volumes. The company's cost-cutting efforts, aiming to capture $2 billion in savings by 2026, are on track, but the recent earnings miss and premium valuation may limit further upside.

1.c. Company Highlights

2. Philip Morris International's Strong 2025 Performance and Promising 2026 Outlook

Philip Morris International Inc. (PMI) reported a robust financial performance for 2025, with total net revenues exceeding $40 billion, driven significantly by its smoke-free products, which generated $17 billion or 41.5% of total net revenues. The company's organic top-line growth was 6.5%, and adjusted diluted EPS growth was 14.2%, surpassing expectations. Adjusted operating income grew by 11.8% to $16.4 billion, and adjusted diluted EPS was $7.54, highlighting the company's strong profitability.

Publication Date: Feb -08

📋 Highlights
  • Smoke-Free Revenue Dominance:: Smoke-free products accounted for 41.5% ($17B) of total $40B net revenues in 2025, up from prior years.
  • Adjusted EPS Growth:: Adjusted diluted EPS surged 14.2% to $7.54, outpacing organic top-line growth of 6.5%.
  • IQOS & ZYN Volume Surge:: Smoke-free volumes grew 12.8%, driven by IQOS shipments +11% (155B units) and ZYN pouches +36% (13.6B units).
  • 2026 Guidance:: PMI targets 5–7% organic revenue growth and 7.5–9.5% EPS growth, with smoke-free product momentum offsetting combustible declines.

Smoke-Free Products Drive Growth

The company's smoke-free products volumes grew by 12.8%, driven by IQOS, which saw shipments grow by 11% to 155 billion units, and nicotine pouches, led by ZYN, which grew by 36% to 13.6 billion pouches. This growth underscores PMI's successful strategy of transitioning towards smoke-free products, a trend that is expected to continue into 2026.

Guidance and Targets for 2026 and Beyond

For 2026, PMI expects another strong performance despite transitory headwinds, including excise tax increases on heat-not-burn products in Japan. The company forecasts organic net revenue growth of 5-7%, driven by continued momentum in smoke-free products and pricing, and EPS growth of 7.5-9.5%. PMI has renewed its medium-term growth targets, aiming for 6-8% organic net revenue growth, 8-10% organic operating income growth, and 9-11% adjusted diluted EPS growth through 2028.

Valuation Metrics

With a P/E Ratio of 23.91 and an EV/EBITDA of 19.03, PMI's valuation reflects its strong growth prospects. The company's Dividend Yield of 3.09% and Free Cash Flow Yield of 3.56% indicate a commitment to returning value to shareholders. The ROIC of 27.97% highlights PMI's ability to generate returns on its invested capital.

Operational Highlights and Challenges

PMI's IQOS product has seen high single-digit growth, with a strong performance in various markets. However, Japan has experienced a slowdown due to increased competition and excise tax hikes. The company is also navigating regulatory challenges, such as the proposed excise tax increase on nicotine pouches in New York, which could impact the competitive landscape.

Cost Efficiency and Innovation

PMI is on track to deliver $2 billion in cost savings by 2026, with a focus on products like IQOS ILUMA and ZYN Ultra. The company is also exploring the potential of AI to drive efficiency and cost savings, which is expected to be a key factor in its future performance.

3. NewsRoom

Card image cap

2 No-Brainer Dividend Stocks to Buy Right Now

Mar -03

Card image cap

Bahl & Gaynor Inc. Purchases 272,622 Shares of Philip Morris International Inc. $PM

Mar -02

Card image cap

Philip Morris International Inc. $PM Position Boosted by 111 Capital

Mar -02

Card image cap

Philip Morris International Inc. $PM Shares Sold by Banco Santander S.A.

Feb -28

Card image cap

Altria vs. Philip Morris: Which Is the Smarter Play for Now?

Feb -27

Card image cap

Choreo LLC Grows Holdings in Philip Morris International Inc. $PM

Feb -27

Card image cap

Artisan Partners Limited Partnership Purchases 24,656 Shares of Philip Morris International Inc. $PM

Feb -27

Card image cap

Citizens Business Bank Takes $458,000 Position in Philip Morris International Inc. $PM

Feb -26

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (7.90%)

6. Segments

Europe

Expected Growth: 6.5%

Europe's mature market and regulatory pressures may slow growth. However, the shift towards alternative nicotine products could drive revenue. A growth rate slightly below the global average is expected due to these balancing factors.

SSEA, CIS & MEA

Expected Growth: 8.5%

Emerging markets within this segment offer higher growth potential due to increasing consumer demand. However, this is somewhat offset by potential regulatory hurdles and public health initiatives. The expected growth rate is above the global average, reflecting the segment's mixed but overall positive outlook.

EA, AU & PMI GTR

Expected Growth: 7.0%

The diverse nature of this segment, with both mature and growing markets, results in a growth rate near the global average. While there are challenges, particularly in regulated markets like Australia, the global travel retail component adds a layer of potential growth tied to the recovery of international travel.

Americas

Expected Growth: 6.0%

The segment faces significant regulatory pressures and declining cigarette sales. While there's potential for growth in alternative nicotine products, the overall growth rate is expected to be below the global average due to these challenges.

Wellness and Healthcare

Expected Growth: 10.0%

The wellness and healthcare segment is poised for significant growth as it represents a new frontier for Philip Morris International. Investments in this area are expected to yield high returns as the company diversifies its portfolio and taps into the growing demand for health and wellness products.

7. Detailed Products

Marlboro

A premium cigarette brand offering a range of flavor profiles and nicotine levels

Chesterfield

A mid-range cigarette brand offering a smooth, balanced taste

L&M

A value cigarette brand offering a range of flavor profiles at an affordable price

iQOS

A heat-not-burn tobacco product offering a smoke-free alternative to cigarettes

HEETS

Tobacco sticks designed for use with iQOS, offering a range of flavor profiles

Marlboro HeatSticks

Tobacco sticks designed for use with iQOS, offering a range of flavor profiles under the Marlboro brand

8. Philip Morris International Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

Philip Morris International Inc. faces moderate threat from substitutes, as consumers have limited alternatives to traditional tobacco products. However, the growing popularity of e-cigarettes and heat-not-burn products poses a threat to the company's traditional cigarette business.

Bargaining Power Of Customers

Philip Morris International Inc. has a large customer base, but individual customers have limited bargaining power due to the addictive nature of tobacco products. Additionally, the company's strong brand portfolio and wide distribution network reduce the bargaining power of customers.

Bargaining Power Of Suppliers

Philip Morris International Inc. has a diversified supplier base, and no single supplier has significant bargaining power. The company's large scale of operations and long-term contracts with suppliers also reduce the bargaining power of suppliers.

Threat Of New Entrants

The tobacco industry has high barriers to entry, including significant regulatory hurdles, high capital requirements, and established distribution networks. These barriers make it difficult for new entrants to compete with established players like Philip Morris International Inc.

Intensity Of Rivalry

The tobacco industry is highly competitive, with several large players competing for market share. Philip Morris International Inc. faces intense competition from other major tobacco companies, such as Altria Group and British American Tobacco, as well as from smaller players and new entrants in the e-cigarette and heat-not-burn markets.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 130.60%
Debt Cost 4.24%
Equity Weight -30.60%
Equity Cost 6.99%
WACC 3.40%
Leverage -426.81%

11. Quality Control: Philip Morris International Inc. passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Altria

A-Score: 7.6/10

Value: 6.8

Growth: 5.8

Quality: 6.5

Yield: 10.0

Momentum: 7.0

Volatility: 9.7

1-Year Total Return ->

Stock-Card
Imperial Brands

A-Score: 7.5/10

Value: 5.6

Growth: 5.0

Quality: 6.4

Yield: 9.4

Momentum: 9.0

Volatility: 9.7

1-Year Total Return ->

Stock-Card
Universal

A-Score: 7.0/10

Value: 8.2

Growth: 5.9

Quality: 4.2

Yield: 10.0

Momentum: 5.0

Volatility: 9.0

1-Year Total Return ->

Stock-Card
Philip Morris

A-Score: 6.8/10

Value: 3.8

Growth: 4.1

Quality: 7.1

Yield: 8.0

Momentum: 8.5

Volatility: 9.0

1-Year Total Return ->

Stock-Card
BAT

A-Score: 6.7/10

Value: 3.0

Growth: 3.6

Quality: 6.1

Yield: 9.4

Momentum: 9.5

Volatility: 8.7

1-Year Total Return ->

Stock-Card
Scandinavian Tobacco Group

A-Score: 6.5/10

Value: 7.6

Growth: 4.0

Quality: 5.4

Yield: 10.0

Momentum: 3.0

Volatility: 9.0

1-Year Total Return ->

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

177.12$

Current Price

177.12$

Potential

-0.00%

Expected Cash-Flows